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Key Clinical Message
Kasabach–Merritt phenomenon can be encountered in the perinatal period. No
consensus exists regarding prenatal management. We report one prenatal case
leading to therapeutic abortion and one neonatal case, successfully treated by a
multimodal therapy. Prenatal counseling should include the possibility of
neonatal multimodal treatment that can lead to favorable outcomes.
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Kasabach–Merritt phenomenon (KMP), first described by
Kasabach and Merritt in 1940, is characterized by pro-
found thrombocytopenia associated with “giant heman-
gioma” [1]. Coagulopathy can be associated with
aggressive presentations. It is now clear that KMP occurs
exclusively with kaposiform hemangioendothelioma
(KHE) or tufted angioma (TA) [2]. Occasionally, a lesion
will have features of both types suggesting that they may
be part of a continuum [3, 4]. In prenatal period, KMP
complicating KHE or TA may be suspected by the sudden
growth of a distinctive solitary vascular tumor. Cardiac
failure as well as nonimmune fetal hydrops may appear
secondarily. Magnetic resonance imaging (MRI) is the
imaging of choice for prenatal diagnosis and follow-up.
Since congenital presentation of KMP is in most cases a
severe condition, its prenatal diagnosis may eventually
lead to discussion of therapeutic abortion [5].
Recently, a consensus-derived practice standards plan
for complicated kaposiform hemangioendothelioma
(occurring after birth, or during childhood), was pub-
lished by a multidisciplinary, multi-institutional expert
panel [6]. However, no such consensus exists for prenatal
management.
The aim of this case series was to report on two peri-
natal cases, including one prenatal case leading to thera-
peutic abortion, and one neonatal case discovered at
birth, successfully treated with a multimodal therapy.
Issues regarding prenatal counseling will also be discussed
at the end of this report.
Case 1
A 27-year-old woman without any personal or family
history was referred to a Multidisciplinary Center of Fetal
Medicine at 26 weeks and 4 days of gestation. A routine
ultrasonography (US) performed 1 week earlier (25 weeks
of gestation), revealed a large soft tissue lesion on the
right thigh of the fetus. Through US, the lesion was found
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to be homogeneous, diffusely hyperechoic, and infiltrating
the soft tissue. A pelvic extension was suspected. The
Doppler study showed hypervascularization of the mass.
An MRI study (Fig. 1), showed a dermo-hypodermic
extension, where the underlying muscles where spared.
The lesion infiltrated the paravesical region and a signifi-
cant edema of the limb was observed. At 26 weeks, US
showed that the lesion had significantly increased in size,
responsible for a marked increase in the circumference of
the thigh. The lesion appeared more heterogeneous and
still highly vascularized. The fetus also presented with
echographic signs of cardiac failure (cardiomegaly, mitral
insufficiency, pathologic Doppler flow of the ductus veno-
sus, and pulsatile umbilical venous flow), fetal hydrops as
well as severe anemia (increased velocity in the middle
cerebral artery). Those imaging features, together with
rapid extension and hemodynamic complication, were
consistent with KHE complicated with KMP. After a mul-
tidisciplinary discussion, termination of pregnancy was
proposed to the parents, due to the rapid extension, the
hemodynamic degradation, and the young age of the
fetus. The parents elected for pregnancy termination at
27 weeks of gestation. A pathological exam confirmed
KHE.
Case 2
A 1-day-old, full-term infant was referred to our neonatal
intensive care unit (NICU) in Lyon for further investiga-
tion of a marked hypertrophy of the left leg, with purple-
brownish discoloration of the skin, sensitive to palpation
(Fig. 2). No anomaly had been detected during preg-
nancy, and high-resolution ultrasound did not reveal fetal
abnormalities or malformations. No hemodynamic disor-
der was observed for the neonate. Profound thrombocy-
topenia (14 9 10⁹/L) and severe anemia (82 g/dL) were
evidenced upon the patient’s arrival. Activated partial
thromboplastin time (46 sec) was minimally elevated. As
well, hypofibrinogenemia (40 mg/dL) appeared secondar-
ily after 3 days. An MRI showed a dermal and subcuta-
neous thickening with ill-defined margins extending into
adjacent muscles of the limb and perineum. Cardiac
ultrasound was normal. Clinical presentation, biological
abnormalities, and imaging features were highly indicative
of combined KHE with KMP. After discussing the
patient’s results at a multidisciplinary meeting which
included a neonatologist, oncologist, radiologist, and der-
matologist, methylprednisolone was started at a 3 mg/kg/
day basis and vincristine on a 0.05 mg/kg weekly basis.
Initial follow-up showed a rapid tumor extension to per-
ineum and chest wall, complicated by respiratory distress
requiring continuous airway pressure support. Ticlopidine
and aspirin were added after 1 week of treatment. Due to
profound anemia, the neonate was treated with recurrent
red blood cells. Platelet transfusion was avoided, in order
to limit platelet consumption and subsequent worsening
of KMP.
Platelets were lowest at 3 9 10⁹/L during the first week.
Progressive improvement was observed after a 3-week-per-
iod, including tumor involution, lightening of the reddish
coloration, and stepwise biological marker normalization
Figure 1. Fetal MRI of case 1. Twenty-five weeks of GA, T2-weighted
sequence performed in the sagittal plane. The lesion is developed in the
dermo-epidermic region (arrow). There is an edematous infiltration of
the limb (arrowhead). Figure 2. Clinical presentation at birth of case 2.
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(platelets 30 9 10⁹/L). With the exception of frequent
vomiting, no treatment side effects were apparent. Corti-
costeroids and ticlid were diminished and stopped after
1 month as aspirin and vincristine were maintained. The
limb was wrapped with compressive bandages, and daily
physiotherapy was introduced to improve mobility of the
leg. Platelet normalization was obtained after 1 month
and a half, and tumor stabilization occurred after
3 months (Fig. 3). However, vincristine was maintained
for 2 years as local recurrence occurred as soon as the
treatment was stopped. At this point, the patient’s psy-
chomotor development was perfectly normal, even though
eating disorders persisted from birth until the age of two.
Follow-up was maintained until the age of five.
KMP is characterized by severe thrombocytopenia due
to platelet trapping within the tumor in contrast to
venous or lymphaticovenous malformations where the
platelet count is minimally depressed. Hypofibrinogene-
mia and fibrinolysis are secondary. Prothrombin time and
activated partial thromboplastin time are normal and ane-
mia is caused by the sequestration of red blood cells in
the tumor [7].
These lesions can be extremely fast-growing and locally
invasive. In the perinatal period, KMP may be associated
with cardiac failure or nonimmune fetal hydrops [5]. The
mortality rate ranges from 20% to 40% according to
world literature [2,8]. On pathology, KHE or TA can be
distinguished from infantile hemangioma, because of
negative endothelial GLUT 1 marker [9].
MRI is the imaging modality of choice for prenatal
diagnosis and follow-up for such condition. Heteroge-
neous soft issue infiltration demonstrating increased T2
intensity, decreased T1 intensity as well as gadolinium-
enhanced images are observed [10]. However, gadolinium
injection should be avoided during pregnancy.
To date, no prenatal effective treatment has been
reported. Whether there is a role for high doses of pla-
centa-crossing steroids or digitalis therapy during preg-
nancy still remains controversial. There is also no
established consensus on exact timing and coordination
of delivery. Extreme prematurity (as in case 1) has been
described to reduce treatment chances, highly increasing
the mortality rate [11]. A better outcome has been
described with moderate prematurity [12]. High output
heart failure and fetal hydrops, frequently associated with
this life-threatening disease, should lead to pluridisci-
plinary discussion of birth induction or therapeutic abor-
tion according to the gestational age of the fetus, despite
the absence of consensus as in case 1.
In case 2, the prenatal diagnosis was not made. Conse-
quently, therapeutic abortion, birth induction, or parents’
preparedness, was not discussed during pregnancy. How-
ever, as our case presented without heart failure or fetal
hydrops during pregnancy (normal ultrasound), it is likely
that neither therapeutic abortion nor birth induction
would have occurred.
In postnatal periods, KHE or TA usually present as soli-
tary, firm red-purplish lesions, involving mostly superficial
soft tissues [13]. KMP is characterized by severe thrombo-
cytopenia due to platelet trapping within the tumor.
Hypofibrinogenemia and fibrinolysis are secondary. Acti-
vated partial thromboplastin time is minimally high and
anemia is caused by the sequestration of red blood cells in
the tumor [7].While biopsy is not mandatory, an MRI is
preferred for accurate diagnosis [2, 6, 14].
Expert recommendations are a first-line therapy with
weekly vincristine for 24 weeks associated with corticos-
teroids which should be weaned after 3–4 weeks [6]. Pla-
telet transfusion is recommended only in case of active
bleeding and/or before immediate surgery. Inconsistent
results are reported from antiplatelet and antifibrinolytic
therapy [6]. Interferon and radiotherapy cannot be used at
a young age, as a first course of treatment [14]. Other
treatments such as embolization, sclerotherapy, and sur-
gery have been reported with variable rates of success [6].
In our neonatal case, no such treatment could be per-
formed due to patient’s age, lesion size, and localization.
A combination of medications, using high dosage of ster-
oids, vincristine, ticlid, and aspirin was used, and led toFigure 3. Aspect of the lower limb after 3 months of multimodal
treatment of case 2.
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rapid improvement. However, vincristine was maintained
for 24 months, due to the risk of local recurrences.
Congenital KMP can be encountered in the perinatal
period. Prenatal presentation can be life threatening, lead-
ing to discussion of termination of pregnancy, particularly
in cases of poor hemodynamic condition. However, pre-
natal counseling should include the possibility of neonatal
management with a multimodal treatment that can lead
to favorable outcomes.
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